Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse OutcomesRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Inflammatory Bowel Diseases|March 26, 2011
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurinesIris Dotan, Lael Werner, Sharon Vigodman, et al.
International Journal of Oncology|April 8, 2010
Dimeric Le(a) (Le(a)-on-Le(a)) status of beta-haptoglobin in sera of colon cancer, chronic inflammatory disease and normal subjectsSeung-Yeol Park, Seon-Joo Yoon, Sen-Itiroh Hakomori, et al.
International Journal of Cancer|June 25, 2009
N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjectsSeung-Yeol Park, Seon-Joo Yoon, Yeon-Tae Jeong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing SurveillanceRemi Mahmoud, Shailja C Shah, Joana Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
BMC Medical Genetics|May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Journal of Crohn'S & Colitis|January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b StudyWilliam J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Pageof 4